New research reveals that people who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who end conventional diet and exercise plans.
Findings released in a major medical journal demonstrates that while obese people can lose about a fifth of their total mass while on the medication, the weight comes back at an average rate of 0.8 kg per month after stopping.
"Individuals purchasing these treatments should be cognizant of the potential of fast weight regain when the therapy is stopped," warns researcher Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment mass within about 18 months.
Analyzing Approaches
The study, which examined 37 of studies involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.
The team note that individuals who lose weight through lifestyle changes alone generally have a slower creep back—perhaps 100 grams monthly—after stopping.
Understanding the Fast Rebound
Nutrition scientists believe the way of the jabs is key to understanding the amplified regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication leads to hunger is unsuppressed, making overeating far more likely."
A Lifelong Condition?
The NHS recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, given the significant potential of weight regain, the treatment is often life-long.
This view is supported by drug manufacturers, who say that the results "highlight the long-term character of excess weight," akin to managing diseases like high blood pressure.
User Accounts
Users who have stopped the jabs explain a intense return of cravings.
"It felt as if a switch activating and you become extremely hungry," said an individual.
This difficulty is worsened if patients have not adopted permanent lifestyle or habit changes during therapy.
Growing Interest
Recent estimates show that millions of people in the UK have tried these injections in the past year, with desire remaining high.
- Adoption is greater among females compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are powerful agents for weight loss, they are not a standalone solution and maintained weight loss hinges on ongoing lifestyle changes.
